Pre-Owned - Excellent PALL iCELLis

Pre-Owned - Excellent
1
2021
In stock
Germany
16 055
(plus shipping costs and VAT)
Price in seller currency:
18 445

Seller:

Germany

Product Details

iCELLis
PALL
Bioreactors
01.10.2025
118

Product Specifications

Yes
Yes
Yes
Yes
Yes

Product Description

Cytiva PALL iCELLis Nano Bioreactor with mPath Control Tower (2021)
SKU: 9276
Manufacturer: Cytiva / Pall
Model: iCELLis Nano bioreactor with mPath control tower (2021)
Description:
The Cytiva PALL iCELLis Nano is a scalable fixed-bed bioreactor specifically designed for the cultivation of adherent cells in gene and cell therapy development. In combination with the mPath control tower, this system provides precise control of all relevant process parameters such as pH, DO, temperature, flow rate and gas control.
The iCELLis Nano is ideal for process development, scale-up studies and pre-clinical applications. The compact design and one-way technology (single use) ensure easy handling, minimal contamination risks and reduced set-up times.
The system from 2021 is in excellent condition and offers state-of-the-art bioprocess control in a small space.
Specifications:
System type: fixed-bed bioreactor for adherent cell culture
Reactor volume: up to 2.67 m2 culture surface
Bioreactor module: iCELLis Nano (disposable, single-use)
Control unit: mPath Control Tower (touchscreen, USB/network connection)
Adjustable parameters:
Temperature
pH
DO (oxygen saturation)
Gases (O, CO, N, air)
Pump control (media supply / removal)
Scalability: iCELLis Nano iCELLis 500
Software: mPath Automation software for real-time control and data acquisition
Technical details:
Power supply: 100-240 V, 50/60 Hz
Dimensions mPath Tower: approx 55 50 70 cm (W D H)
Dimensions iCELLis Nano module: about 30 40 50 cm
Weight: about 40 kg (total)
Materials: Bioreactor: single-use plastic; Tower: stainless steel / ABS housing
Communication: USB, Ethernet, optional SCADA compatible
Condition:
The iCELLis Nano system with mPath control from 2021 is in a very good used condition. It has been used only a few times, is fully functional, and is ideally suited for the development of cell therapy and viral vector production processes on a laboratory scale.